Tag: central nervous system disorders

September 17, 2017

5 Top NASDAQ Biotech Stocks: CASI Pharmaceuticals Leads the Pack

CASI Pharmaceuticals, Savara, Adverum Biotechnologies, ChromaDex Therapeutics and MannKind top the NASDAQ biotech stock list.
September 3, 2017

5 Top NASDAQ Biotech Stocks: Neovasc Leads the Week

Neovasc, Adaptimmune, Curis, Vericel and MannKind top the NASDAQ biotech stock list.
August 20, 2017

5 Top NASDAQ Biotech Stocks: Delcath Systems Takes the Week

Delcath Systems, MannKind, Zogenix, BioLife Solutions and BioDelivery Sciences top the NASDAQ biotech stock list.
April 27, 2017

VistaGen's AV-101 Featured in Peer-Reviewed Publication

VistaGen Therapeutics announced the publication of a nonclinical study on the effects of AV-101, the company's central nervous system disorder...